Related Experiment Video
Updated: May 4, 2026

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
Pattern of and risk factors for brain microbleeds in neurodegenerative dementia
Javier Olazarán1, Ana Ramos, Inmaculada Boyano
11Alzheimer Disease Research Unit, Alzheimer Center Reina Sofía Foundation-CIEN Foundation, Carlos III Institute of Health, Madrid, Spain.
Objective:
A cross-sectional study was conducted to describe the prevalence, locations, and risk factors for brain microbleeds (BMBs) in neurodegenerative dementia.
Methods:
The database of the Alzheimer Center Reina Sofía Foundation was searched, BMBs were described, and the potential associations of BMBs were investigated using univariate statistics.
Results:
A total of 148 patients (age 81.6 [standard deviation 6.7], 79.1% female) were studied. Prevalence of BMBs was 44.6%. A group of patients with unusually high (ie, ≥4) number of BMBs were identified, which displayed higher number of vascular risk factors and vascular diseases. Brain microbleeds were also associated with ischemic lesions in the basal ganglia (r = .39), clinical diagnosis of Alzheimer's disease (AD) and cerebrovascular disease (r = .33), cortical infarction (r = .20), and antiaggregant or anticoagulant treatment duration (r = .20).
Conclusions:
Brain microbleeds are associated with vascular burden and AD diagnosis in old patients with neurodegenerative dementia. More research is warranted regarding the mechanisms and potential clinical implications of these results.
Insights
Brain microbleeds (BMBs) are common in neurodegenerative dementia, affecting nearly half of patients. These BMBs are linked to vascular issues and Alzheimer's disease diagnosis.
Area of Science:
- Neurology
- Neuroimaging
- Geriatrics
Background:
- Neurodegenerative dementia is a growing public health concern.
- Brain microbleeds (BMBs) are increasingly recognized as potential markers in neurological disorders.
- Understanding BMBs' prevalence and associations is crucial for patient management.
Purpose of the Study:
- To determine the prevalence, locations, and risk factors of BMBs in patients with neurodegenerative dementia.
- To investigate associations between BMBs and other neurological and vascular conditions.
Main Methods:
- Cross-sectional study utilizing data from the Alzheimer Center Reina Sofía Foundation database.
- Description and quantification of BMBs.
- Univariate statistical analysis to identify potential associations.
Main Results:
- Prevalence of BMBs was 44.6% in the studied cohort (n=148).
- Patients with a high number of BMBs (≥4) had more vascular risk factors and diseases.
- BMBs correlated with ischemic lesions, Alzheimer's disease (AD) diagnosis, cerebrovascular disease, cortical infarction, and anticoagulant/antiplatelet treatment duration.
Conclusions:
- BMBs are significantly associated with vascular burden and AD diagnosis in older adults with neurodegenerative dementia.
- Further research is needed to elucidate the underlying mechanisms and clinical implications of BMBs in this population.
Related Concept Videos
Dementia l: Introduction
Alzheimer Disease l: Introduction
Hemorrhagic Stroke l: Introduction
Alzheimer Disease ll: Pathophysiology
Dementia
The progression of dementia is generally gradual....
Cerebral Edema ll: Pathophysiology

